TrialBritish journal of clinical pharmacology2020

The first-in-human study of CNTO 7160, an anti-interleukin-33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis.

Ivo Nnane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.